New Delhi, March 2 (IANS) Global and Indian airlines cancelled and diverted hundreds of flights for a third straight day on Monday after the escalating US-Israel and Iran war prompted widespread airspace closures across West Asia and the Gulf.
New Delhi, March 2 (IANS) The manufacturing PMI in India rose from 55.4 in January to a four-month high of 56.9 in February, as a substantial improvement in domestic demand for Indian goods fuelled new order intakes and spurred the greatest upturn in production volumes for four months, S&P Global data showed on Monday.
New Delhi, March 2 (IANS) A Morgan Stanley report on Monday said it expects the growth impulse to remain strong in India, and see upside to its growth forecast of 6.5 per cent for FY27, driven by continued tailwinds for both domestic and external demand.
New Delhi, March 2 (IANS) Gold and silver prices jumped over 3 per cent on Monday, after the US-Iran war intensified amid Israeli strikes on Iran and the US bases in the Gulf, reinforcing safe-haven demand.
Mumbai, March 2 (IANS) The Indian equity markets opened the week sharply lower on Monday, tracking a broad risk-off sentiment across global markets due to the US, Israel and Iran war.
New Delhi, March 2 (IANS) Global crude oil prices went up more than 7 per cent on Monday as war in West Asia escalated, following US and Israeli military strikes on Iran.
New Delhi, March 1 (IANS) The global aviation industry is under heavy strain after rising military tensions involving the United States, Israel, and Iran triggered widespread airspace closures across West Asia, disrupting flight operations around the world.
New Delhi, March 1 (IANS) Bharti Airtel and Google on Sunday announced a collaboration to offer a safer and more engaging messaging experience for millions of users in India.
New Delhi, March 1 (IANS) Pakistan’s internet troubles have once again come into focus after conflicting reports emerged about the government’s so-called “firewall” system ahead of the upcoming 5G spectrum auction, a report has said.
New Delhi, March 1 (IANS) The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over $500 million, according to sources cited by multiple reports.
